Well Lead Medical Co., Ltd. (SHA:603309)
China
· Delayed Price · Currency is CNY 13.72
+0.16 (1.18%)
Apr 29, 2026, 3:00 PM CST
Well Lead Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,004 | 3,967 | 3,509 | 4,172 | 5,861 | 4,176 | Upgrade
|
| Market Cap Growth | 10.00% | 13.05% | -15.90% | -28.82% | 40.35% | 28.18% | Upgrade
|
| Enterprise Value | 4,118 | 4,176 | 3,675 | 3,991 | 5,495 | 4,254 | Upgrade
|
| Last Close Price | 13.72 | 13.40 | 11.33 | 12.93 | 17.84 | 13.99 | Upgrade
|
| PE Ratio | 51.67 | 51.97 | 15.99 | 21.67 | 35.18 | 39.36 | Upgrade
|
| Forward PE | 12.70 | 80.30 | 80.30 | 80.30 | 80.30 | 80.30 | Upgrade
|
| PS Ratio | 2.44 | 2.43 | 2.33 | 3.01 | 4.30 | 3.73 | Upgrade
|
| PB Ratio | 2.18 | 2.23 | 1.84 | 2.27 | 3.37 | 2.62 | Upgrade
|
| P/TBV Ratio | 2.65 | 2.74 | 2.49 | 3.08 | 4.66 | 3.79 | Upgrade
|
| P/FCF Ratio | 25.12 | 31.96 | - | - | 27.94 | 53.53 | Upgrade
|
| P/OCF Ratio | 10.44 | 12.01 | 11.46 | 18.75 | 14.98 | 22.30 | Upgrade
|
| EV/Sales Ratio | 2.51 | 2.56 | 2.44 | 2.88 | 4.03 | 3.80 | Upgrade
|
| EV/EBITDA Ratio | 10.15 | 10.83 | 11.58 | 13.41 | 21.68 | 21.43 | Upgrade
|
| EV/EBIT Ratio | 13.23 | 13.71 | 14.42 | 17.02 | 27.87 | 28.52 | Upgrade
|
| EV/FCF Ratio | 25.83 | 33.65 | - | - | 26.20 | 54.54 | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.34 | 0.27 | 0.22 | 0.15 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 1.37 | 1.52 | 1.56 | 1.29 | 0.99 | 1.18 | Upgrade
|
| Debt / FCF Ratio | 3.49 | 4.83 | - | - | 1.24 | 3.14 | Upgrade
|
| Net Debt / Equity Ratio | 0.05 | 0.05 | 0.02 | -0.03 | -0.25 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.24 | 0.21 | 0.09 | -0.17 | -1.75 | -1.97 | Upgrade
|
| Net Debt / FCF Ratio | 0.61 | 0.65 | -2.95 | 0.37 | -2.12 | -5.00 | Upgrade
|
| Asset Turnover | 0.59 | 0.57 | 0.55 | 0.56 | 0.60 | 0.62 | Upgrade
|
| Inventory Turnover | 5.00 | 5.04 | 5.43 | 4.98 | 4.74 | 4.29 | Upgrade
|
| Quick Ratio | 1.38 | 1.19 | 1.32 | 1.47 | 1.70 | 1.83 | Upgrade
|
| Current Ratio | 1.83 | 1.52 | 1.67 | 1.85 | 2.08 | 2.29 | Upgrade
|
| Return on Equity (ROE) | 4.65% | 4.74% | 12.22% | 11.44% | 10.67% | 8.38% | Upgrade
|
| Return on Assets (ROA) | 6.97% | 6.68% | 5.85% | 5.87% | 5.46% | 5.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.02% | 10.76% | 11.91% | 13.11% | 13.65% | 10.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.70% | 13.70% | 11.00% | 10.80% | 10.30% | 8.70% | Upgrade
|
| Earnings Yield | 1.93% | 1.92% | 6.25% | 4.61% | 2.84% | 2.54% | Upgrade
|
| FCF Yield | 3.98% | 3.13% | -0.27% | -3.25% | 3.58% | 1.87% | Upgrade
|
| Dividend Yield | 2.95% | - | 4.41% | 3.87% | 1.91% | 0.97% | Upgrade
|
| Payout Ratio | 280.79% | 208.57% | 70.93% | 55.50% | 27.31% | 55.20% | Upgrade
|
| Buyback Yield / Dilution | 0.34% | -0.36% | -0.30% | 0.20% | -12.93% | 0.29% | Upgrade
|
| Total Shareholder Return | 3.23% | -0.36% | 4.11% | 4.07% | -11.03% | 1.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.